Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedRespiratory news
Overuse of asthma reliever inhalers ‘a major contributor’ to CO2 emissions in respiratory care
Overuse of short-acting bronchodilator inhalers in...
Phyllocontin to be discontinued
Phyllocontin Continus 225mg and Phyllocontin Forte...
Third triple combination inhaler launched for COPD
Trixeo Aerosphere is a new treatment for COPD patients,...
New LABA/LAMA combination inhaler increases choice for COPD patients
Bevespi Aerosphere (formoterol/glycopyrronium) is a...
First triple combination MDI licensed for asthma
Trimbow (beclometasone/formoterol/glycopyrronium) can...
New low-dose LABA/corticosteroid inhaler for asthma
A lower-dose metered-dose inhaler has been added to...
First 3-in-1 inhaler for asthma launched
Enerzair Breezhaler is the first triple combination...
Consider bisphosphonates to combat osteoporosis risk in asthma patients taking steroids, say researchers
New research has linked oral and inhaled steroids to...
Honey 'more effective than antibiotics' for respiratory infections
Honey is better than usual care for easing upper respiratory...
High prescribing of short-acting reliever inhalers 'suggests asthma guidance not being followed'
Frequent prescribing of short-acting ß2 agonists (SABA)...
Stepping down of asthma treatment 'worryingly infrequent' despite clinical and cost benefits
Asthma guidelines recommend stepping down of medication...
Delayed antibiotic prescribing for URTIs increases hospital admission risk, study shows
Delaying the prescription of antibiotics in patients...
MIMS launches Respiratory and Allergy Learning webinars
Join us for the 2020 Respiratory and Allergy Learning...
NICE releases rapid guidance for primary care clinicians during COVID-19 pandemic
New guidance on the care of patients with suspected...
Inhaler prescribing guidance issued as spike in demand causes shortages
Prescribers have been urged not to extend repeat prescription...
NICE overturns advice to increase steroid dose in children with asthma
NICE has withdrawn its recommendation to quadruple...
Free respiratory and allergy workshops announced
The MIMS Workshops Respiratory and Allergy Learning...
PHE issues coronavirus guidance for primary care
Public Health England (PHE) has issued guidance for...
Triple therapy 'potentially best option' for stable COPD patients
Triple therapy with a long-acting muscarinic antagonist...
MHRA advises prescribers to consider carefully the benefits and neuropsychiatric risks of montelukast
Prescribers should be alert for possible neuropsychiatric...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.